InspireMD Q2 Loss Widens to $14.3M; Cash Drops to $30.4M Amid Recall Fallout
NSPR sits 67% above its 52-week low of $0.63 on elevated volume (3.8× avg).
Summary
InspireMD reported a wider Q2 net loss of $14.3M and a cash balance of $30.4M, down sharply from year-end, as the CGuard Prime recall drove negative U.S. revenue and inventory write-downs.
Key Events · Earnings and Guidance · NSPR
-
Q2 Net Loss Widens to $14.3M
Net loss for Q2 2026 was $14.324M, or $0.17 per share, compared to $13.151M, or $0.26 per share, in Q2 2025.
-
Recall Drives Negative U.S. Revenue
U.S. revenue was $(351K) in Q2 2026, reflecting $734K of customer credits from the voluntary recall of the CGuard Prime 135cm delivery system, which exceeded gross U.S. product sales.
-
Gross Loss of $774K on Inventory Impairment
Gross loss was $774K, including a $612K inventory impairment charge and $734K in customer credits, both tied to the recall.
-
Cash Position Drops to $30.4M
Cash, cash equivalents, and marketable securities totaled $30.421M as of June 30, 2026, down from $54.211M at December 31, 2025, heightening going-concern risk.
Analysis · NSPR · Industrial Applications And Services
InspireMD's second quarter shows the financial damage from the voluntary recall of its CGuard Prime 135cm delivery system. Revenue was flat at $1.77M, but U.S. revenue turned negative due to $734K in customer credits, and gross profit swung to a $774K loss after a $612K inventory impairment. Net loss widened to $14.3M. Cash and marketable securities fell to $30.4M from $54.2M at year-end, intensifying the going-concern risk already flagged in prior filings. The company announced $9M in annual cost savings and expects FDA decisions on two products later this year, but the near-term liquidity picture is deteriorating.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NSPR was trading at $1.05 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $46M. The 52-week trading range was $0.63 to $2.57. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.